Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

First Trust NYSE Arca Biotechnology Index Fund (FBT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
142.12 -3.22    -2.22%
11:54:35 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 22,415
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 141.50 - 143.36
Type:  ETF
Market:  United States
Issuer:  First Trust
Asset Class:  Equity
First Trust NYSE Arca Biotech 142.12 -3.22 -2.22%

FBT Recent Sentiments

 
Information on users’ sentiments for the First Trust NYSE Arca Biotech ETF, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Jan 12, 2024 rajeev vengurlekar   155.83 Feb 02, 2024 @ 148.96 -4.41%
Nov 08, 2023 Emiaj Sedivaneb   140.89 Nov 30, 2023 @ 140.25 -0.45%
Jun 26, 2023 Maurício Omm   152.64 Nov 30, 2023 @ 140.25 -8.12%
Jun 06, 2023 נדב שכטר   157.66 Nov 30, 2023 @ 140.25 -11.04%
Apr 12, 2023 Square Jo   156.45 Apr 12, 2023 @ 156.45 0.00%
Oct 24, 2022 Gianni Gioda   137.51 Nov 18, 2022 @ 152.10 +10.61%
Jun 09, 2022 庸之 鈴木   134.64 Jul 01, 2022 @ 138.98 +3.22%
May 12, 2022 Carlos GH   128.18 Jun 03, 2022 @ 135.11 +5.41%
May 04, 2022 Gabriel Pa   138.33 May 30, 2022 @ 138.58 +0.18%
Jan 10, 2022 Leonel Aguilera   150.72 Feb 04, 2022 @ 148.94 +1.18%
Dec 09, 2021 Michel Falcão   156.78 Dec 31, 2021 @ 161.96 +3.30%
Sep 01, 2021 성원 김   173.94 Sep 24, 2021 @ 172.90 -0.60%
Jun 18, 2021 Daniel Gonzalez   172.08 Jul 09, 2021 @ 173.03 +0.55%
Aug 26, 2020 TG Ivanov   156.86 Sep 18, 2020 @ 157.24 +0.24%
Aug 12, 2020 john pawl   164.44 Sep 04, 2020 @ 153.57 -6.61%
Jul 06, 2020 LUCAS PORTUGA   170.54 Jul 31, 2020 @ 165.74 -2.81%
Jun 25, 2020 Edgar Reyes   169.82 Jul 17, 2020 @ 177.01 +4.23%
May 11, 2020 Vladimir Petrov   161.08 Jun 05, 2020 @ 163.29 +1.37%
Dec 24, 2019 Leon Schild   153.05 Jan 17, 2020 @ 152.05 -0.65%
Sep 11, 2019 Ken Hansen   129.96 Oct 04, 2019 @ 123.82 -4.72%
Jul 23, 2019 Hugo Snyman   136.66 Aug 16, 2019 @ 133.95 -1.98%
Jun 24, 2019 Francisco Ruiz   137.73 Jul 19, 2019 @ 137.19 -0.39%
Jun 05, 2019 Hugo Snyman   132.88 Jun 28, 2019 @ 140.77 +5.94%
Feb 06, 2019 Daniel Marinho   144.64 Mar 08, 2019 @ 142.31 +1.61%
Jul 24, 2018 jm landaluce   151.78 Aug 07, 2018 @ 152.05 +0.18%
Jun 20, 2018 jm landaluce   147.43 Jun 20, 2018 @ 148.00 +0.39%
Mar 22, 2018 Fernando Menéndez   138.31 Apr 21, 2018 @ 134.60 -2.68%
Feb 02, 2018 jm landaluce   140.06 Feb 02, 2018 @ 140.58 +0.37%
Nov 29, 2017 jm landaluce   122.70 Nov 29, 2017 @ 123.37 +0.55%
Nov 07, 2017 jm landaluce   121.81 Nov 08, 2017 @ 122.13 +0.26%
Oct 05, 2017 jm landaluce   127.26 Nov 04, 2017 @ 123.98 -2.58%
Oct 04, 2017 jm landaluce   126.46 Oct 04, 2017 @ 126.60 +0.11%
Sep 27, 2017 jm landaluce   122.97 Sep 28, 2017 @ 123.23 +0.21%
Sep 22, 2017 jm landaluce   123.03 Sep 25, 2017 @ 123.68 +0.53%
Sep 22, 2017 jm landaluce   122.92 Sep 22, 2017 @ 123.06 +0.11%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

FBT Comments

Write your thoughts about First Trust NYSE Arca Biotechnology Index Fund
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email